Latent HIV cells only ‘wake up’ once a week following antiretrovirals

A new study published in PLOS Pathogens provides new insight into how often HIV cells “wake up” among individuals undergoing antiretroviral therapy for the virus, bringing researchers one step closer to getting patients off the treatment for good and into remission.

The study was conducted by Prof. Miles Davenport and colleagues from the Kirby Institute at the University of New South Wales (UNSW) in Australia. “Researchers have been looking at ways of reducing the amount of latent HIV infection in the body, in the hopes of creating a remission so that drug therapy can be suspended,” says Professor Davenport, “but until now we didn’t know exactly how long it takes for the latent HIV cells to reactivate and start infecting other cells again after treatment is suspended.”

Read more at Medical News Today.

ART latency remission study